| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/29/2010 | CN101926832A Rat molding method for acute viral rhinitis |
| 12/29/2010 | CN101926307A Establishment method of animal model in mice infected with sparganosis mansoni |
| 12/29/2010 | CN101487775B Use of borneol preparation in tissue optical clearing agent preparation |
| 12/29/2010 | CA2766272A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery |
| 12/29/2010 | CA2765418A1 Therapeutic antibody target validation and screening in vivo |
| 12/28/2010 | US7860549 Method and apparatus for 3-D imaging of internal light sources |
| 12/28/2010 | US7858578 Methods of inducing neuronal growth by a Fucose-α(1-2) galactose (fuc-α(1-2) gal) moiety and a lectin |
| 12/28/2010 | US7858349 Anti-cancer compounds |
| 12/28/2010 | US7858327 Using terminal kinase mutant as model for identifying modulator which treat, prevent or reduce incidence of premature aging; enzyme inhbitors; insulin receptor effectors |
| 12/28/2010 | US7858116 hepatocyte targeted composition comprising mixture of free recombinant human insulin isophane and free recombinant human regular insulin and mixture of recombinant human insulin isophane and recombinant human regular insulin associated with water insoluble target molecule complex; diabetes treatment |
| 12/28/2010 | US7858093 Single-dose such as vaccines, based on bioerodible polyanhydride copolymer or homopolymer microparticles |
| 12/28/2010 | US7858073 By recognising significant variability in the capacity of different isolates of a microbe to activate antigen-presenting cells and T-lymphocytes, a method of evaluating capacity to activate antigen responsive cells and lymphocytes against abnormal microbial colonisation of a mucosal surface |
| 12/28/2010 | US7858072 radiolabeled compounds such as (4-(2-(4-(2-(2-(2-(2-(2-(2-(2-(2-Fluoro-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethoxy)-phenyl)-vinyl)-phenyl)-methyl-amine, used for quantitating amyloid deposits |
| 12/28/2010 | US7858071 Biomarkers for amyotrophic lateral sclerosis |
| 12/28/2010 | US7858070 fusion propteins; homogeneous purity, and unaltered affinity, and can be produced in high yields without the requirement of extensive purification; stable in serum to allow in vivo applications |
| 12/23/2010 | WO2010145035A1 Renal cell carcinoma biomarkers |
| 12/23/2010 | WO2010020798A3 Nanoparticles |
| 12/23/2010 | WO2009135937A3 Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging |
| 12/23/2010 | US20100324416 Cavity-filling biopsy site markers |
| 12/23/2010 | US20100322870 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
| 12/23/2010 | US20100322869 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy |
| 12/23/2010 | US20100322868 Contrast agents |
| 12/23/2010 | US20100322867 Biomedical materials |
| 12/23/2010 | US20100322866 Device, system and method for in-vivo analysis |
| 12/23/2010 | US20100322865 Deuterated metabolic water precursor for detecting and treating diseased tissue |
| 12/23/2010 | US20100322864 Telemetry through remote detection of nmr-active particles |
| 12/23/2010 | US20100322863 Methods and Uses of Anti-IL-23 Antibodies |
| 12/23/2010 | US20100322862 Methods and compositions using peptides and proteins with c-terminal elements |
| 12/23/2010 | US20100322861 Engineered cells, imaging report gene/probe systems, and methods of imaging |
| 12/23/2010 | US20100322860 Method for determination of a potential mutation |
| 12/23/2010 | US20100322859 Oral drug compliance monitoring using magnetic-field sensors |
| 12/23/2010 | US20100322858 Radiohaloimatinibs and Methods of Their Synthesis and Use in PET Imaging of Cancers |
| 12/23/2010 | US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
| 12/23/2010 | US20100322853 Nanoparticulate compositions of angiogenesis inhibitors |
| 12/23/2010 | US20100322852 Nanoparticulate compositions of angiogenesis inhibitors |
| 12/23/2010 | US20100322850 New plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells |
| 12/23/2010 | CA2765870A1 Renal cell carcinoma biomarkers |
| 12/22/2010 | EP2264018A2 Thioflavin derivatives for use in the diagnosis of Alzheimer's disease |
| 12/22/2010 | EP2263453A1 Transgenic animal model of neurodegenerative disorders |
| 12/22/2010 | EP2262541A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 12/22/2010 | CN1849136B Cancerous disease modifying antibodies |
| 12/22/2010 | CN101925366A Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 12/22/2010 | CN101923932A Multifunctional double-layer core-shell structure magnetic nano particle, preparation method and application thereof |
| 12/22/2010 | CN101921732A A virus causing respiratory tract illness in susceptible mammals |
| 12/22/2010 | CN101921164A Synthesis of (1)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates, and composition and uses thereof |
| 12/22/2010 | CN101920023A Transrectal ultrasound medical coupling agent |
| 12/22/2010 | CN101362066B Preparation method of liposome embedded quantum dots silicon dioxide microspheres and products thereof |
| 12/21/2010 | US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy |
| 12/21/2010 | US7854918 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 12/21/2010 | CA2457145C Assay method for alzheimer's disease |
| 12/16/2010 | WO2010143942A1 Targeted nano-photomedicines for photodynamic therapy of cancer |
| 12/16/2010 | WO2010143708A1 Targeting agent for neovascularization |
| 12/16/2010 | WO2010143172A1 Conjugates of cell- penetrating peptides and phosphorescent metalloporphyrins for intracellular oxygen measurement |
| 12/16/2010 | WO2010079079A3 PDGF-Rβ BINDERS |
| 12/16/2010 | US20100319074 Multi-targeted rnai therapeutics for scarless wound healing of skin |
| 12/16/2010 | US20100316575 Modulating body weight |
| 12/16/2010 | US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy |
| 12/16/2010 | US20100316573 Organic Compounds |
| 12/16/2010 | US20100316572 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 12/16/2010 | US20100316571 Method and Compositions for Polymer Nanocarriers Containing Therapeutic Molecules |
| 12/16/2010 | US20100316570 Protection of Virus from Immune Cell Uptake |
| 12/16/2010 | US20100316569 Novel peptides |
| 12/16/2010 | US20100316568 Diagnostic agent and therapeutic agent for pancreatic cancer |
| 12/16/2010 | US20100316566 Radiolabeled hedgehog derivatives for imaging and therapy |
| 12/16/2010 | US20100316565 Novel imaging method |
| 12/16/2010 | US20100316564 Immunological targeting of pathological tau proteins |
| 12/16/2010 | CA2802334A1 Compositions and methods for imaging tissues, organs and tumors |
| 12/15/2010 | EP2261667A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and their therapy of ovarian cancer |
| 12/15/2010 | EP2260875A2 Folate-receptor targeted imaging agents |
| 12/15/2010 | EP2260865A1 Cancerous disease modifying antibodies |
| 12/15/2010 | EP2260725A2 Process for Preparing Concentrate Thickener Compositions |
| 12/15/2010 | EP2260724A2 Process for preparing concentrate thickener compositions |
| 12/15/2010 | EP2260723A2 Process for Preparing Concentrate Thickener Compositions |
| 12/15/2010 | EP2260722A2 Process for Preparing Concentrate Thickener Compositions |
| 12/15/2010 | EP1839677B1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof |
| 12/15/2010 | EP1556386B1 High purity phthalein derivatives and method for preparing same |
| 12/15/2010 | EP1539818B1 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 12/15/2010 | EP1112077B1 Method for detection of biological factors in epidermis |
| 12/15/2010 | EP1017425B2 Improved methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator |
| 12/15/2010 | CN1988848B Carboranylporphyrins and uses thereof |
| 12/15/2010 | CN101918038A Diagnostic substances for optical imaging testing on the basis of nanoparticular formulations |
| 12/15/2010 | CN101914547A Construction and application of transgenic human APP double mutant gene Alzheimer's disease mouse model |
| 12/15/2010 | CN101912624A Active targeting polymer nanoparticle magnetic resonance contrast agent and preparation method thereof |
| 12/15/2010 | CN101912623A Preparation and application of Fe-Gd double-mode magnetic resonance contrast agent with targeting function |
| 12/15/2010 | CN101912622A Targeted micro-bubble probe for magnetic resonance imaging and blood pressure monitoring and preparation method thereof |
| 12/15/2010 | CN101293878B Benzothiazole amino benzenes compounds, preparation method and application thereof |
| 12/14/2010 | US7850995 having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery |
| 12/14/2010 | US7850946 intramolecular linked drug/biological conjugates, that absorb and emit light in the near infrared region of electromagnetic spectrum, having improved stability, high receptor binding affinity and pharmacokinetics, useful as imaging or contrast agents |
| 12/14/2010 | US7850152 Methods and devices for moisturizing hyperpolarized noble gases and associated moisturized pharmaceutical grade inhalable hyperpolarized gas products |
| 12/14/2010 | US7850008 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 12/09/2010 | WO2010141883A1 Compounds that modulate autoimmunity and methods of using the same |
| 12/09/2010 | WO2010141833A2 Vital fluorochrome conjugates and methods of use |
| 12/09/2010 | WO2010141704A2 Imaging of myelin basic protein |
| 12/09/2010 | WO2010139072A1 Hybrid-multimodal magneto-optical contrast marker |
| 12/09/2010 | WO2010139003A1 Chelating amphiphiles |
| 12/09/2010 | WO2010028817A3 Labelled adiponectin derivatives |
| 12/09/2010 | WO2009142525A3 Capsulating system binding to nucleolin |
| 12/09/2010 | US20100313282 pathological animal model simultaneously developing testicular pain or discomfort behaviors and urinary frequency |
| 12/09/2010 | US20100311962 Agents For Magnetic Imaging Method |
| 12/09/2010 | US20100310872 Nanofunctional silica particles and manufacturing method thereof |